ЛИТЕРАТУРА

Поставить закладку

Витебская A.B. Антропометрические, гормональные, рентгенологические и молекулярногенетические проявления идиопатической низкорослости у детей. Диссертация канд. мед. наук. Москва, 2003.
Дедов И.И., Петеркова В.А. Детская эндокринология: руководство. Москва, 2006.
Солтаханов Э.М. Семейная низкорослость: патогенез, оптимизация методов диагностики и лечения. Диссертация канд. мед. наук. Москва, 1996.
Шандин А.Н. Клинические варианты и молекулярные основы идиопатической низкорослости у детей. Диссертация канд. мед. наук. Москва, 2011.
Шандин А.Н., Нагаева Е.В., Петеркова В.А., Дедов И.И. Эффективность и безопасность применения рекомбинантного гормона роста у детей с идиопатической низкорослостью. Проблемы эндокринологии. 2010; 56(6):14-23.
Шандин А.Н., Петеркова В.А. Классификация, диагностика и лечение идиопатической низкорослости. Проблемы эндокринологии. 2009; 55(4):36-43.
Национальный консенсус. Диагностика и лечение соматотропной недостаточности у детей. - М, 2005.
Blair JC, Camacho-Hübner C, Miraki Moud F, Rosberg S et al. Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature. Clin Endocrinol (Oxf). 2004 Feb;60(2):163-8
Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature: A Summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology Workshop / J. Clin. Endocrinol. Metab. 2008 Sep 9.
De Luca F, Argente J, Cavallo L, Crowne E et al. International Workshop on Management of Puberty for Optimum Auxological Results. Management of puberty in constitutional delay of growth and puberty. J Pediatr Endocrinol Metab. 2001; 14 Suppl 2:953-7.
Hero M, Wickman S, Dunkel L. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty. Clin Endocrinol (Oxf). 2006; 64:510-3.
Lindsay R, Feldkamp M, Harris D, Robertson J et al. Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr. 1994; 125:29-35.
Mauras, N Gonzalez de Pijem L, Hsiang HY, Desrosiers P et al. Anastrozole Increases Predicted Adult Height of Short Adolescent Males Treated With Growth Hormone: A Randomized, Double-blind, Placebo-Controlled Multicenter Trial For One To Three Years. J Clin Endocrinol Metab 2007 Dec 28
Pediatric Endocrinology (5th edition), by F.Lifshitz, Informa Healthcare USA, Inc., 2007.
Quigley CA, Gill AM, Crowe BJ, Robling K et al. Safety of growth hormone treatment in pediatric patients with idiopathic short stature. J Clin Endocrinol Metab. 2005; 90:5188-96.
Ranke M.B., Towards a consensus on the definition of idiopathic short stature, Summary, Horm. Res. 45 (Suppl. 2) (1996) 64–66.
Rekers-Mombarg L.T.M., Wit J.M., Massa G.G. et al. Spontaneous growth in idiopathic short stature, Arch. Dis. Child. 75 (1996) 175–180.
Rosenfeld R.G., The molecular basis of idiopathic short stature, Growth Hormone IGF Res. 15 (2005) S3–S5.
Rosenfeld R.G., Albertsson-Wikland K., Cassorla F. et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited, J. Clin. Endocrinol. Metab. 80 (1995) 1532– 1540.
Ross JL, Sandberg DE, Rose SR, Leschek EW et al. Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo. J Clin Endocrinol Metab. 2004; 89:4873-8.
Selva KA, Buckway CK, Sexton G, Pratt KL et al. Reproducibility in patterns of IGF generation with special reference to idiopathic short stature. Horm Res. 2003;60(5):237-46
Smyczyńska J, Lewiński A, Hilczer M, Stawerska R et al. Partial growth hormone deficiency (GHD) in children has more similarities to idiopathic short stature than to severe GHD. Endokrynol Pol. 2007 May-Jun;58(3):182-7.
Tanaka T. Sufficiently long-term treatment with combined growth hormone and gonadotropin- releasing hormone analogue can improve adult height in short children with isolated growth hormone deficiency (GHD) and non-GHD short children. Pediatric Endocrine Reviews. 2007; 5:471-481.
van Gool SA, Kamp GA, Visser-van Balen H, Mul D et al. Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty. J Clin Endocrinol Metab. 2007; 92:1402-8.
Visser-van Balen H, Geenen R, Kamp GA, Huisman J et al. Long-term psychosocial consequences of hormone treatment for short stature. Acta Paediatr. 2007; 96:715-9
Walenkamp MJ, Wit JM: Genetic disorders in the growth hormone- insulin-like growth factor-1- axis. Horm Res 2006; 66:221-230.
Walton-Betancourth S., Martinelli C.E., Thalange N.K.S., Dyke M.P. et al. Excellent growth response to growth hormone therapy in a child with PTPN11-negative Noonan syndrome and features of growth hormone resistance. J. Endocrinol. Invest. 30: 439-441, 2007.
Wit JM, Clayton PE, Rogol AD, Savage MO et al. Idiopathic short stature: Definition, epidemiology, and diagnostic evaluation. /Growth Horm IGF Res. 2008 Jan 5.
Wit J.M., Ranke M.B., Kelnar C.J.H. ESPE classification of paediatric endocrine diagnoses, Horm. Res. 68 (Suppl. 2) (2007) 1–120.
Wit JM, Reiter EO, Ross JL, Saenger PH et al. Idiopathic short stature: Management and growth hormone treatment. /Growth Horm IGF Res. 2008 Jan 4.
Yanovski JA, Rose SR, Municchi G, Pescovitz OH et al. Treatment with a luteinizing hormone- releasing hormone agonist in adolescents with short stature. N Engl J Med. 2003; 348:908-17.

Для продолжения работы требуется Registration

Предыдущая страница

Следующая страница

Список сокращений

1. МЕТОЛОГИЯ

2. ОПРЕДЕЛЕНИЕ И КЛАССИФИКАЦИЯ

3. ДИАГНОСТИКА ИДИОПАТИЧЕСКОЙ НИЗКОРОСЛОСТИ

4. ЛЕЧЕНИЕ ИДИОПАТИЧЕСКОЙ НИЗКОРОСЛОСТИ

ЛИТЕРАТУРА

Данный блок поддерживает скрол*

ЛИТЕРАТУРА

Table of contents